Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Study indicates potential of KRN-5500 in the treatment of leukemia and lymphoma

June 3, 1999

U. of Alberta designs new bis-benzimidazole anticancer agents

June 3, 1999

Academic investigators describe new agent for BNCT

June 3, 1999

Merck researchers discover nonpeptide GnRH antagonist series

June 3, 1999

Suppression of NF-kappaB enhances antitumor activity of TNF-alpha and CPT-11 via increased apoptosis

June 3, 1999

Oncolytics Biotech enters reovirus development agreement

June 3, 1999

Mitsubishi Chemical group describes inhibitors of EGF TK and tumor cell proliferation

June 2, 1999

Licensing opportunity from Fox Chase Cancer Center: MDR-reversing agents

June 2, 1999

Bavarian Nordic's tyrosinase vector enters safety study in Germany

June 2, 1999

Radiolabeled somatostatin analogue with potential for PET imaging and targeted radiotherapy

June 1, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...